Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Choosing between equal and cap weight depends on goals and risk tolerance. This quick guide compares the two for retirement suitability.
24,468 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
When a high-profile TV season is shelved, the ripple effects go beyond the screen. This article breaks down the finan...
The prospect of SpaceX going public has investors buzzing. History shows mega IPOs behave in patterns that can surpri...
Amazon dethroned Walmart to take the No. 1 spot on the Fortune 500 as revenue surged in 2025. CFO Brian Olsavsky stee...
The SNPD ETF is widening its search for dividend growth by applying a 10-year growth screen to identify the next gene...
In the fast-moving world of perpetual futures, two decentralized venues—Lighter and Hyperliquid—shape where traders p...
Two power players, two very different paths to steady income. This guide breaks down how Constellation Energy and Nex...
If you have $500 to invest, choosing between Bitcoin and Gold for a 3-year hold can shape your portfolio. This guide ...
AI-driven capex sustains a two-horse race in semiconductors. This piece weighs which is the better semi stock to buy ...
Two big drivers could push Truist stock higher in 2026: cheaper funding and faster loan growth. This article breaks d...